Cargando…
Development and validation of an UHPLC-Orbitrap-HRMS method for rapid determination of endogenous L-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use
BACKGROUND: L-carnitine is an endogenous vitamin-like amino acid derivate which plays an essential role in energy metabolism and can be easily lost via dialysis. Deficiency of L-carnitine has great effects on many aspects of bodily functions. To determine the deficiency degree and adjust the supplem...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848361/ https://www.ncbi.nlm.nih.gov/pubmed/35282068 http://dx.doi.org/10.21037/atm-21-6784 |
_version_ | 1784652232261632000 |
---|---|
author | Jiang, Wen-Ting Tang, Liu-Xing Pan, Jie Su, Cun-Jin Shen, Zhu Hu, Zhan-Hong Zhan, Zhou-Bing Shi, Ai-Ming |
author_facet | Jiang, Wen-Ting Tang, Liu-Xing Pan, Jie Su, Cun-Jin Shen, Zhu Hu, Zhan-Hong Zhan, Zhou-Bing Shi, Ai-Ming |
author_sort | Jiang, Wen-Ting |
collection | PubMed |
description | BACKGROUND: L-carnitine is an endogenous vitamin-like amino acid derivate which plays an essential role in energy metabolism and can be easily lost via dialysis. Deficiency of L-carnitine has great effects on many aspects of bodily functions. To determine the deficiency degree and adjust the supplementation dose, a rapid, sensitive, and specific method for the detection of endogenous L-carnitine in the plasma of dialysis patients using ultra-high performance liquid chromatography-Orbitrap high resolution mass spectrometry (UHPLC-Orbitrap-HRMS) was developed and validated. METHODS: The plasma samples were processed by protein precipitation and centrifugation before analysis using UHPLC-Orbitrap-HRMS. Sample separation was achieved with a hydrophilic interaction liquid chromatography (HILIC) column, using an isocratic elution with a runtime of 5 min. The separated analytes were detected by positive ionization mode in full scan mode and targeted-single ion monitoring (t-SIM) mode. Mildronate was used as the internal standard (IS). RESULTS: All the plasma could be detected in the range of 6.169 to 197.394 µM, with adequate accuracy, precision, and recovery. The method was validated in fortified validation with relative standard deviations (RSD) 5.15–8.74%. This method was applied to the analysis of 105 dialysis patients and 39 healthy participants, the results revealed that peritoneal dialysis patients without L-carnitine supplementation should pay more attention to L-carnitine monitoring, meanwhile, all the hemodialysis patients were advised to be routinely given a full dose of L-carnitine, no matter whether they had taken L-carnitine or not. CONCLUSIONS: This study developed a simple and rapid UHPLC-Orbitrap-HRMS method for detection of endogenous L-carnitine in dialysis patients, which could be useful to promote rational drug use. |
format | Online Article Text |
id | pubmed-8848361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-88483612022-03-10 Development and validation of an UHPLC-Orbitrap-HRMS method for rapid determination of endogenous L-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use Jiang, Wen-Ting Tang, Liu-Xing Pan, Jie Su, Cun-Jin Shen, Zhu Hu, Zhan-Hong Zhan, Zhou-Bing Shi, Ai-Ming Ann Transl Med Original Article BACKGROUND: L-carnitine is an endogenous vitamin-like amino acid derivate which plays an essential role in energy metabolism and can be easily lost via dialysis. Deficiency of L-carnitine has great effects on many aspects of bodily functions. To determine the deficiency degree and adjust the supplementation dose, a rapid, sensitive, and specific method for the detection of endogenous L-carnitine in the plasma of dialysis patients using ultra-high performance liquid chromatography-Orbitrap high resolution mass spectrometry (UHPLC-Orbitrap-HRMS) was developed and validated. METHODS: The plasma samples were processed by protein precipitation and centrifugation before analysis using UHPLC-Orbitrap-HRMS. Sample separation was achieved with a hydrophilic interaction liquid chromatography (HILIC) column, using an isocratic elution with a runtime of 5 min. The separated analytes were detected by positive ionization mode in full scan mode and targeted-single ion monitoring (t-SIM) mode. Mildronate was used as the internal standard (IS). RESULTS: All the plasma could be detected in the range of 6.169 to 197.394 µM, with adequate accuracy, precision, and recovery. The method was validated in fortified validation with relative standard deviations (RSD) 5.15–8.74%. This method was applied to the analysis of 105 dialysis patients and 39 healthy participants, the results revealed that peritoneal dialysis patients without L-carnitine supplementation should pay more attention to L-carnitine monitoring, meanwhile, all the hemodialysis patients were advised to be routinely given a full dose of L-carnitine, no matter whether they had taken L-carnitine or not. CONCLUSIONS: This study developed a simple and rapid UHPLC-Orbitrap-HRMS method for detection of endogenous L-carnitine in dialysis patients, which could be useful to promote rational drug use. AME Publishing Company 2022-01 /pmc/articles/PMC8848361/ /pubmed/35282068 http://dx.doi.org/10.21037/atm-21-6784 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Jiang, Wen-Ting Tang, Liu-Xing Pan, Jie Su, Cun-Jin Shen, Zhu Hu, Zhan-Hong Zhan, Zhou-Bing Shi, Ai-Ming Development and validation of an UHPLC-Orbitrap-HRMS method for rapid determination of endogenous L-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use |
title | Development and validation of an UHPLC-Orbitrap-HRMS method for rapid determination of endogenous L-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use |
title_full | Development and validation of an UHPLC-Orbitrap-HRMS method for rapid determination of endogenous L-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use |
title_fullStr | Development and validation of an UHPLC-Orbitrap-HRMS method for rapid determination of endogenous L-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use |
title_full_unstemmed | Development and validation of an UHPLC-Orbitrap-HRMS method for rapid determination of endogenous L-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use |
title_short | Development and validation of an UHPLC-Orbitrap-HRMS method for rapid determination of endogenous L-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use |
title_sort | development and validation of an uhplc-orbitrap-hrms method for rapid determination of endogenous l-carnitine in patients on hemodialysis/peritoneal dialysis and its application to promote rational drug use |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848361/ https://www.ncbi.nlm.nih.gov/pubmed/35282068 http://dx.doi.org/10.21037/atm-21-6784 |
work_keys_str_mv | AT jiangwenting developmentandvalidationofanuhplcorbitraphrmsmethodforrapiddeterminationofendogenouslcarnitineinpatientsonhemodialysisperitonealdialysisanditsapplicationtopromoterationaldruguse AT tangliuxing developmentandvalidationofanuhplcorbitraphrmsmethodforrapiddeterminationofendogenouslcarnitineinpatientsonhemodialysisperitonealdialysisanditsapplicationtopromoterationaldruguse AT panjie developmentandvalidationofanuhplcorbitraphrmsmethodforrapiddeterminationofendogenouslcarnitineinpatientsonhemodialysisperitonealdialysisanditsapplicationtopromoterationaldruguse AT sucunjin developmentandvalidationofanuhplcorbitraphrmsmethodforrapiddeterminationofendogenouslcarnitineinpatientsonhemodialysisperitonealdialysisanditsapplicationtopromoterationaldruguse AT shenzhu developmentandvalidationofanuhplcorbitraphrmsmethodforrapiddeterminationofendogenouslcarnitineinpatientsonhemodialysisperitonealdialysisanditsapplicationtopromoterationaldruguse AT huzhanhong developmentandvalidationofanuhplcorbitraphrmsmethodforrapiddeterminationofendogenouslcarnitineinpatientsonhemodialysisperitonealdialysisanditsapplicationtopromoterationaldruguse AT zhanzhoubing developmentandvalidationofanuhplcorbitraphrmsmethodforrapiddeterminationofendogenouslcarnitineinpatientsonhemodialysisperitonealdialysisanditsapplicationtopromoterationaldruguse AT shiaiming developmentandvalidationofanuhplcorbitraphrmsmethodforrapiddeterminationofendogenouslcarnitineinpatientsonhemodialysisperitonealdialysisanditsapplicationtopromoterationaldruguse |